Abbott eyes $20B bond sale to fund purchase of Exact Sciences – report

Abbott Laboratories (ABT) is seeking to raise nearly $20B through a sale of bonds to finance its previously announced acquisition of Exact Sciences (EXAS).
Bond maturities range from three years to 40 years, Bloomberg reported, citing individuals with knowledge of the matter.
The $21B deal was announced in November. It was approved by Exact Sciences shareholders on Feb. 20.